Myocardial Ischemia
Conditions
Brief summary
The objective of study is to compare the anti-ischemic efficacy and safety profiles of once daily amlodipine or isosorbide-5-mononitrate in the treatment of stable asymptomatic and symptomatic myocardial ischemia
Interventions
Sponsors
Study design
Eligibility
Inclusion criteria
* Outpatients \> =18 years of age with diagnosed clinically stable angina pectoris
Exclusion criteria
* Patients with congestive heart failure, clinically significant cardiovascular disease, standing systolic blood pressure of less than 100mmHg, concomitant anti-anginal therapies similar to sublingual NTG
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluate the time to 1mm ST depression | — |
Secondary
| Measure | Time frame |
|---|---|
| The number of patients experiencing angina attacks The frequency of hospitalizations due to angina attacks Time to onset of 1mm ST segment depression Total external workload performed Safety | — |
Countries
Greece